How 'Clean' Energy Supply Policies & AI Demand Squeeze Utilities & Consumers

How 'Clean' Energy Supply Policies & AI Demand Squeeze Utilities & Consumers

In this episode, we dive into the escalating energy crisis in Illinois, where the massive power and water demands of new AI data centers are colliding head-on with the state’s clean energy goals and aging grid infrastructure. Join us as we unpack the contentious spring 2026 legislative battle over the POWER Act, the competing interests of tech giants, environmentalists, and labor unions, and the Governor’s executive demands. Tune in to understand what these high-stakes policy debates mean for your utility bills, local resources, and the future of tech development in the state. And to review the Governor’s proposed framework for negotiations this summer, https://gov-pritzker-newsroom.prezly.com/gov-pritzker-pauses-new-data-center-tax-incentives [https://gov-pritzker-newsroom.prezly.com/gov-pritzker-pauses-new-data-center-tax-incentives]. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit ilcapitolgroup.substack.com [https://ilcapitolgroup.substack.com?utm_medium=podcast&utm_campaign=CTA_1]

Illinois as a Case Study on Medical Billing Reforms

Wrapping up our mini-series on the economics of healthcare, this episode unpacks the rigorous legislative negotiations behind the Illinois Transparency in Downcoding Act. We explore how the tension between medical providers fighting for clinical autonomy and insurers prioritizing operational automation resulted in a unique “human-in-the-loop” transparency framework regulating AI in insurance claims. Tune in to learn how this hard-fought state compromise could serve as a national model for broader medical billing reform across federally regulated health plans. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit ilcapitolgroup.substack.com [https://ilcapitolgroup.substack.com?utm_medium=podcast&utm_campaign=CTA_1]

Final Compromise on a 340B Study to See How Millions are Spent Every Year

In this 340B follow-up episode, we track the rapid advancement of companion legislation during the final days of the legislative session, detailing its mandate for a comprehensive study to establish baseline data on the state’s 340B drug program. We explore the study’s expanded scope to audit both medical providers and pharmaceutical manufacturers, alongside the industry’s critical testimony regarding illegal duplicate discounts and $286 million in displaced Medicaid rebates. Tune in to understand how this four-year data collection initiative could ultimately shape the operational survival of local safety-net clinics and the future cost of commercial insurance premiums. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit ilcapitolgroup.substack.com [https://ilcapitolgroup.substack.com?utm_medium=podcast&utm_campaign=CTA_1]

The Future of a Prescription Drug Program Fundamental to Safety Net Healthcare

In the final week of the Illinois legislative session, lawmakers are racing to reconcile competing billion-dollar interests involving discount drug pricing reform. This episode examines how a newly proposed transparency “trailer bill” attempts to force a compromise for a medical provider-protection bill that has stalled since last year. Tune in to understand how this high-stakes legislative showdown balances the survival of safety-net clinics with demands for strict financial accounting and the oversight of corporate middlemen. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit ilcapitolgroup.substack.com [https://ilcapitolgroup.substack.com?utm_medium=podcast&utm_campaign=CTA_1]

How States Struggle to Make Prescriptions Affordable

In this episode, we examine the proposed Illinois Prescription Drug Affordability Board (PDAB) and how it fits into the national landscape of drug pricing and competing stakeholder interests clashing over the policy. Tune in to understand how the legislation evolved from a broad initial proposal into a heavily amended, five-year pilot program designed to address supply chain vulnerabilities while still accomplishing its fundamental goal of prescription affordability. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit ilcapitolgroup.substack.com [https://ilcapitolgroup.substack.com?utm_medium=podcast&utm_campaign=CTA_1]